Sphingosine-1-phosphate (S1P), by inhibiting MMPs and promoting glycocalyx synthesis, has shown protective effects in preclinical models
During this consultation, medical professionals should assess your medical history, discuss potential risks, and allow you to ask questions about the treatment
Portala, K., Westermark, K., von Knorring, L
Both peptides have minimal known drug interactions due to their natural occurrence and specific mechanisms of action
The longevity of the results varies depending on the treatment, but we will recommend when to return for a second shot. All of our injectables are approved by Health Canada, and our team is certified to administer IV therapy safely and comfortably
Exercise optimization during combination therapy The right exercise approach amplifies the effects of both compounds while protecting lean mass